The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP for lichen planopilaris. Check out this month’s issue highlights straight from the JDD Editor’s desk:
Guest Editor Dr. James Q. Del Rosso explains how recent advances are opening doors for patients seeking treatment for this common skin disorder in Never Give Up! Continued Progress in Development of Topical Therapies for Acne Is a Good Thing.
Improving Rosacea Outcomes in Skin of Color Patients: A Review on the Nuances in the Treatment and the Use of Cleansers and Moisturizers assesses how adding over-the-counter products can help SOC.
Advances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% Cream concludes that once-daily application is most effective and convenient for the age group targeted.
Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Adult Age Groups examines data in participants 18–24 and 25+.
Authors argue that more attention is needed from healthcare providers treating children in The Many Faces of Pediatric Acne: How to Tailor Nonprescription Acne Treatment and Skincare Using Cleansers and Moisturizers.
Psychosocial Burden of Verruca Vulgaris: A Cross-Sectional Survey aims to analyze the reported effects on quality of life in adults diagnosed with and treated for common warts and their satisfaction with the different therapeutic modalities.
Hormonal Therapies in the Management of Acne Vulgaris performs a literature search using electronic database MEDLINE/PUBMED through June 2021.
The Use of Bakuchiol in Dermatology: A Review of In Vitro and In Vivo Evidence considers potential as an alternative treatment therapy for acne, post-inflammatory hyperpigmentation (PIH), anti-aging, psoriasis, and skin cancer.
The consensus of the panel in Evidence Threshold for a Precision Medicine Test that Predicts Optimal Response to a Biologic Agent in Patients With Psoriasis: A Consensus Panel was that the MATCH study is sufficient to prove the clinical utility of the Mind.Px test.
Probiotics Supplementation Improves Quality of Life, Clinical Symptoms, and Inflammatory Status in Patients With Psoriasis presents a randomized double-blind placebo controlled clinical trial at Tabriz University of Medical Sciences (TBZMED) in Iran.
A Prospective, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy, Safety, and Patient Satisfaction of Tretinoin 0.05% Lotion for Chest Rejuvenation addresses the increasing need for treatments that are well tolerated and associated with little to no downtime.
Improving Body Skin Quality: Evidence-Based Development of Topical Treatment and Survey of Current Options describes efforts to characterize not only the important elements of skin quality but also the key biological pathways that are crucial to restoring or repairing those elements when they are lost or compromised by aging or other causes.
Subgroup Analyses by European Country-Specific Reimbursement Requirements Confirm Efficacy for Ixekizumab in Psoriasis includes baseline and 12-week data from the ixekizumab- and etanercept-treated study populations from UNCOVER-2 and -3.
Successful Outpatient Management of Diffuse Photosensitive Bullous Dermatitis Following Pembrolizumab Therapy reports two cases involving >50% total body surface area successfully treated in the outpatient setting with oral dexamethasone and minimal to no interruption of PD-1 inhibitor therapy.
Although literature has limited evidence on treatments for this challenging disease, Reversible Hair Loss in Lichen Planopilaris: Regrowth With Low-Dose Naltrexone and Platelet-Rich Plasma demonstrates remarkable results in the case of a female patient with LPP.
Diversity in Academic Dermatology explores underrepresentation within the medical specialty and proposes more equality through leadership roles.
Through data collected, Barriers to Care-Seeking and Treatment Adherence Among Dermatology Patients: A Cross-Sectional National Survey Study highlights the high prevalence, common barriers, and risk factors of care avoidance and nonadherence in dermatology.
Treatment Update of Port-Wine Stain responds to an article on PWS published in May 2021’s issue of JDD.
Using PubMed and Google Scholar databases, the authors review published literature from 1934-2021 and select 9 studies in Oral Vitamin A for Acne Management: A Possible Substitute for Isotretinoin.
Find more JDD Issue Highlights here.
